BioVie Inc. (BIVI) Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioVie Inc. on April 18, 2024. The Company is a Nevada corporation with its principal executive offices in Carson City, NV. Its Class A Common Stock trades on The Nasdaq Stock Market under the symbol "BIVI".
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. The only financial metric disclosed is that the Company currently holds stockholders' equity of at least $5 million, which qualifies it for potential consideration of a listing extension.
Material Changes and Listing Status
On April 18, 2024, the Company received notice from Nasdaq that its common stock bid price had closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Consequently, the Company has been granted a 180-calendar-day grace period ending October 15, 2024, to regain compliance. To maintain listing, the Company must achieve a closing bid price of at least $1.00 per share for 10 consecutive business days within this period.
Outlook, Risks, and Management Commentary
Management states it is diligently working to regain compliance but offers no assurance of success. If the Company fails to meet the $1.00 bid price requirement by October 15, 2024, it may seek a second 180-day grace period, contingent upon meeting the market value of publicly held shares and other initial listing standards (excluding the bid price). The filing highlights significant risks, including the potential for delisting, the ability to raise capital, cash on hand limitations, and uncertainties regarding clinical studies and product approvals.
Key Facts for Investor Verification
- Delisting Risk: The stock is currently non-compliant with Nasdaq's minimum bid price rule and faces potential delisting if compliance is not achieved by October 15, 2024.
- Compliance Path: The Company must sustain a $1.00+ closing bid price for 10 consecutive trading days within the grace period.
- Extension Criteria: Eligibility for a second grace period depends on maintaining at least $5 million in stockholders' equity and meeting other initial listing standards.
- Financial Data: This 8-K contains no operational financial results; investors should refer to recent 10-Q or 10-K filings for revenue and cash position details.